Michael Kleines
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michael Kleines has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Krüttgen
Laboratory Diagnostic Center, RWTH Aachen University Hospital, Aachen, Germany
6 shared publications Klaus Ritter
Division of Virology, Department of Medical Microbiology, UK Aachen, RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany
5 shared publications- Matthias Imöhl
Laboratory Diagnostic Center, University Hospital RWTH Aachen, Aachen, Germany
5 shared publications Simone Scheithauer
4 shared publicationsMartin Häusler
3 shared publications- Martin Häusler
Division of Neuropediatrics and Social Pediatrics, Department of Pediatrics, University Hospital RWTH Aachen, 52074 Aachen, Germany
3 shared publications
Latest Publications
- Open Access
- 1 March 2025
- Published by Georg Thieme Verlag KG in Krankenhaushygiene up2date
- Vol. 20 (01) , 65-77
Erregerlexikon: RSV (Repiratorisches Synzytial-Virus)
Das RSV verursacht schwer verlaufende Infektionen der unteren Atemwege bei Kleinkindern und Menschen über 65 Jahren. Seit Mitte 2024 werden von der STIKO ein neuer passiver Impfstoff mit vereinfachter Applikation und besserer Wirksamkeit für alle Säuglinge und 2 aktive Impfstoffe für über 60-Jährige empfohlen. Ein weiterer aktiver Impfstoff ist in der EU bereits zugelassen. Zudem sind erfolgversprechende antivirale Wirkstoffe in der Entwicklung. Article published online: 01 March 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 1 March 2025
- Published by Georg Thieme Verlag KG in Krankenhaushygiene up2date
- Vol. 20 (01) , 65-77
Open AccessErregerlexikon: RSV (Repiratorisches Synzytial-Virus)
Das RSV verursacht schwer verlaufende Infektionen der unteren Atemwege bei Kleinkindern und Menschen über 65 Jahren. Seit Mitte 2024 werden von der STIKO ein neuer passiver Impfstoff mit vereinfachter Applikation und besserer Wirksamkeit für alle Säuglinge und 2 aktive Impfstoffe für über 60-Jährige empfohlen. Ein weiterer aktiver Impfstoff ist in der EU bereits zugelassen. Zudem sind erfolgversprechende antivirale Wirkstoffe in der Entwicklung. Article published online: 01 March 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 14 November 2023
- Published by Springer Nature in Diagnostic Pathology
- Vol. 18 (1) , 1-8
Detection of HHV-6 Virus in specimen of a ductal pancreatic adenocarcinoma with comparison in tumor and normal tissue
The association of human herpesvirus 6 (HHV-6) species with pancreatic cancer is controversially discussed. The aim of this study was to further investigate the postulated association and to identify the basis of HHV-6 DNA positivity reported for pancreatic cancer tissue. All samples of patients with pancreatic cancer (cancer and surrounding tissue) were analyzed for presence of HHV-6 DNA by PCR and then selected cases by immunohistochemistry. Sixty eight per cent (68% = 52/77) of all patients were HHV-6 DNA positive in any of the samples, 49% (38/77) were positive in tumor tissue. Specimens of just one patient were HHV-6A DNA positive, all other patients were positive for HHV-6B. Immunohistochemical analysis of HHV-6 DNA positive samples did not reveal any specific HHV-6B protein positive tumor cell. In contrast, supposed immune cells presented intra- and peritumorally expressed HHV-6B-protein. The cause of presence of these cells in the tumor stroma is unknown, as of yet. HHV-6 DNA-positivity of pancreatic cancer tissue described by us and others is probably not due to the infection of pancreatic cells by HHV-6, but rather due to the migration of HHV-6 positive immune cells into the pancreas. Based on our data, we suppose that there is no direct evidence for HHV-6 as a causative agent of pancreatic cancer, but further in-depth studies (including investigation of immune status of patients) are necessary to make definitive conclusions.
- 14 November 2023
- Published by Springer Nature in Diagnostic Pathology
- Vol. 18 (1) , 1-8
Open AccessDetection of HHV-6 Virus in specimen of a ductal pancreatic adenocarcinoma with comparison in tumor and normal tissue
The association of human herpesvirus 6 (HHV-6) species with pancreatic cancer is controversially discussed. The aim of this study was to further investigate the postulated association and to identify the basis of HHV-6 DNA positivity reported for pancreatic cancer tissue. All samples of patients with pancreatic cancer (cancer and surrounding tissue) were analyzed for presence of HHV-6 DNA by PCR and then selected cases by immunohistochemistry. Sixty eight per cent (68% = 52/77) of all patients were HHV-6 DNA positive in any of the samples, 49% (38/77) were positive in tumor tissue. Specimens of just one patient were HHV-6A DNA positive, all other patients were positive for HHV-6B. Immunohistochemical analysis of HHV-6 DNA positive samples did not reveal any specific HHV-6B protein positive tumor cell. In contrast, supposed immune cells presented intra- and peritumorally expressed HHV-6B-protein. The cause of presence of these cells in the tumor stroma is unknown, as of yet. HHV-6 DNA-positivity of pancreatic cancer tissue described by us and others is probably not due to the infection of pancreatic cells by HHV-6, but rather due to the migration of HHV-6 positive immune cells into the pancreas. Based on our data, we suppose that there is no direct evidence for HHV-6 as a causative agent of pancreatic cancer, but further in-depth studies (including investigation of immune status of patients) are necessary to make definitive conclusions.
- Open Access
- 1 January 2023
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 12 (1) , 60-69
Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions DMD TNR
Klingel H, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):60-69. https://doi.org/10.7774/cevr.2023.12.1.60
- 1 January 2023
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 12 (1) , 60-69
Open AccessHumoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions DMD TNR
Klingel H, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):60-69. https://doi.org/10.7774/cevr.2023.12.1.60
- 27 September 2022
- Published by Georg Thieme Verlag KG in OP-Management up2date
- Vol. 2 (03) , 237-251
Nachweisverfahren in der SARS-CoV-2-Diagnostik – Antigen-, Antikörper-, und Nukleinsäure-basierte Tests
Das Beobachten und die Kontrolle des Verlaufs der SARS-CoV-2-Pandemie erfordert die Identifizierung akut erkrankter Personen, infektiöser Individuen, immuner Personen, von Personen mit zurückliegender Infektion und von Trägern einer Virusvariante mit erhöhtem pathogenem Potenzial. Jede Analysemethode adressiert diese Anforderungen unterschiedlich gut, sodass sie je nach Fragestellung differenziert eingesetzt werden müssen. Article published online: 27 September 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 27 September 2022
- Published by Georg Thieme Verlag KG in OP-Management up2date
- Vol. 2 (03) , 237-251
Nachweisverfahren in der SARS-CoV-2-Diagnostik – Antigen-, Antikörper-, und Nukleinsäure-basierte Tests
Das Beobachten und die Kontrolle des Verlaufs der SARS-CoV-2-Pandemie erfordert die Identifizierung akut erkrankter Personen, infektiöser Individuen, immuner Personen, von Personen mit zurückliegender Infektion und von Trägern einer Virusvariante mit erhöhtem pathogenem Potenzial. Jede Analysemethode adressiert diese Anforderungen unterschiedlich gut, sodass sie je nach Fragestellung differenziert eingesetzt werden müssen. Article published online: 27 September 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 2 June 2022
- Published by Georg Thieme Verlag KG in Krankenhaushygiene up2date
- Vol. 17 (02) , 125-139
Nachweisverfahren in der SARS-CoV-2-Diagnostik – Antigen-, Antikörper-, und Nukleinsäure-basierte Tests
Das Beobachten und die Kontrolle des Verlaufs der SARS-CoV-2-Pandemie erfordert die Identifizierung akut erkrankter Personen, infektiöser Individuen, immuner Personen, von Personen mit zurückliegender Infektion und von Trägern einer Virusvariante mit erhöhtem pathogenem Potenzial. Jede Analysemethode adressiert diese Anforderungen unterschiedlich gut, sodass sie je nach Fragestellung differenziert eingesetzt werden müssen. Article published online: 02 June 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 2 June 2022
- Published by Georg Thieme Verlag KG in Krankenhaushygiene up2date
- Vol. 17 (02) , 125-139
Nachweisverfahren in der SARS-CoV-2-Diagnostik – Antigen-, Antikörper-, und Nukleinsäure-basierte Tests
Das Beobachten und die Kontrolle des Verlaufs der SARS-CoV-2-Pandemie erfordert die Identifizierung akut erkrankter Personen, infektiöser Individuen, immuner Personen, von Personen mit zurückliegender Infektion und von Trägern einer Virusvariante mit erhöhtem pathogenem Potenzial. Jede Analysemethode adressiert diese Anforderungen unterschiedlich gut, sodass sie je nach Fragestellung differenziert eingesetzt werden müssen. Article published online: 02 June 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 10 March 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (7) , 3087-3095
The SARS‐CoV‐2 pandemic in Germany may represent the sum of a large number of local but independent epidemics each initiated by individuals aged 10–19 years, middle‐aged males, or elderly individuals
Many epidemiological aspects of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemics, particularly those affecting children, are still sparsely elucidated. Data on the first pandemic phase during the year 2020 indicated that children might serve as a virus reservoir. We now analyzed data on more than 530 000 SARS‐CoV‐2 polymerase chain reaction (PCR) and 12 503 anti‐SARS‐CoV‐2 antibody tests performed in the west of Germany until Week 4 of 2021. We show that children of at least 10 years of age may play a prominent role in the pandemic showing highest PCR‐positive rates in the first (Weeks 28–35), second (Weeks 42–48), and third wave (Week 50 of 2020–Week 2 2021) of the second pandemic phase, although the waves were not mainly initiated by children. The waves' kinetics differed even in nearby cities. Low PCR‐positive rates were confined to areas of lower population density. PCR‐positive rates were higher among middle‐aged males compared with women and among very old females compared with males. From Week 25, seroprevalence rates slowly increased to 50%, indicating ongoing virus activity. In conclusion, the SARS‐CoV‐2 pandemics is characterized by many local but interacting epidemics, initiated and driven by different social groups. Children may not be the main initiators of virus spreading but older children may significantly affect the course of the pandemic. High population density is associated with higher SARS‐CoV‐2 incidence.
- 10 March 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (7) , 3087-3095
Open AccessThe SARS‐CoV‐2 pandemic in Germany may represent the sum of a large number of local but independent epidemics each initiated by individuals aged 10–19 years, middle‐aged males, or elderly individuals
Many epidemiological aspects of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemics, particularly those affecting children, are still sparsely elucidated. Data on the first pandemic phase during the year 2020 indicated that children might serve as a virus reservoir. We now analyzed data on more than 530 000 SARS‐CoV‐2 polymerase chain reaction (PCR) and 12 503 anti‐SARS‐CoV‐2 antibody tests performed in the west of Germany until Week 4 of 2021. We show that children of at least 10 years of age may play a prominent role in the pandemic showing highest PCR‐positive rates in the first (Weeks 28–35), second (Weeks 42–48), and third wave (Week 50 of 2020–Week 2 2021) of the second pandemic phase, although the waves were not mainly initiated by children. The waves' kinetics differed even in nearby cities. Low PCR‐positive rates were confined to areas of lower population density. PCR‐positive rates were higher among middle‐aged males compared with women and among very old females compared with males. From Week 25, seroprevalence rates slowly increased to 50%, indicating ongoing virus activity. In conclusion, the SARS‐CoV‐2 pandemics is characterized by many local but interacting epidemics, initiated and driven by different social groups. Children may not be the main initiators of virus spreading but older children may significantly affect the course of the pandemic. High population density is associated with higher SARS‐CoV‐2 incidence.
- Open Access
- 1 January 2022
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 11 (1) , 96-103
Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers
Krüttgen A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):96-103. https://doi.org/10.7774/cevr.2022.11.1.96
- 1 January 2022
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 11 (1) , 96-103
Open AccessLarge inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers
Krüttgen A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):96-103. https://doi.org/10.7774/cevr.2022.11.1.96
- Open Access
- 1 January 2022
- Published by Korean Vaccine Society in Clinical and Experimental Vaccine Research
- Vol. 11 (1) , 121-124
Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers
Klingel H, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):121-124. https://doi.org/10.7774/cevr.2022.11.1.121
- 1 January 2022
- Published by Korean Vaccine Society in Clinical and Experimental Vaccine Research
- Vol. 11 (1) , 121-124
Open AccessSeverity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers
Klingel H, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):121-124. https://doi.org/10.7774/cevr.2022.11.1.121
- 23 September 2021
- Published by Elsevier in Journal of Virological Methods
- Vol. 299, 114297
Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273
- 23 September 2021
- Published by Elsevier in Journal of Virological Methods
- Vol. 299, 114297
Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273